Katsuaki Maehara/X
Oct 29, 2024, 17:46
Katsuaki Maehara: EGFRm Unresectable Stage III lung cancer in LAURA and POLESTAR trials
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X:
“EGFRm Unresectable Stage III lung cancer.
LAURA and POLESTAR.
INDIRECT
- Tend to ‘high’ disease progression or death. (IMO)
- Are EGFRm positive lung cancers still highly malignant ? (IMO)
- It seems as if it is a systemic disease. (IMO).”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19